Search results for " methylation"

showing 10 items of 457 documents

Recommendations for a nomenclature system for reporting methylation aberrations in imprinted domains

2018

The analysis of DNA methylation has become routine in the pipeline for diagnosis of imprinting disorders, with many publications reporting aberrant methylation associated with imprinted differentially methylated regions (DMRs). However, comparisons between these studies are routinely hampered by the lack of consistency in reporting sites of methylation evaluated. To avoid confusion surrounding nomenclature, special care is needed to communicate results accurately, especially between scientists and other health care professionals. Within the European Network for Human Congenital Imprinting Disorders we have discussed these issues and designed a nomenclature for naming imprinted DMRs as well …

Epigenomics0301 basic medicineCancer ResearchADNMedizinBiologyBioinformaticsMethylationGenomic Imprinting03 medical and health sciences0302 clinical medicineTerminology as TopicHealth careJournal Articleimprinting disordersAnimalsHumansPoint of ViewMolecular BiologyNomenclaturePolymorphism GeneticAberrant methylationbusiness.industryImprintingDNAMethylationDNA Methylation3. Good health030104 developmental biologyDifferentially methylated regions030220 oncology & carcinogenesisPractice Guidelines as TopicDNA methylationnomenclatureHuman genomemethylationSpecial careMetilacióbusinessEpigenetics
researchProduct

The Association Between Epigenetic Clocks and Physical Functioning in Older Women: A 3-Year Follow-up

2021

Abstract Background Epigenetic clocks are composite markers developed to predict chronological age or mortality risk from DNA methylation (DNAm) data. The present study investigated the associations between 4 epigenetic clocks (Horvath’s and Hannum’s DNAmAge and DNAm GrimAge and PhenoAge) and physical functioning during a 3-year follow-up. Method We studied 63- to 76-year-old women (N = 413) from the Finnish Twin Study on Aging. DNAm was measured from blood samples at baseline. Age acceleration (AgeAccel), that is, discrepancy between chronological age and DNAm age, was determined as residuals from linear model. Physical functioning was assessed under standardized laboratory conditions at b…

EpigenomicsAgingfyysinen toimintakykyEpigenesis Genetic03 medical and health sciences0302 clinical medicinePhysical functioningMedicineHumans030212 general & internal medicineEpigeneticsAssociation (psychology)030304 developmental biology0303 health sciencesbusiness.industryLinear modelRepeated measures designdNaMDNA MethylationMissing dataTwin studyDNA-metylaatioikääntyminenCross-Sectional Studiesepigenetiikkabiological aging3121 General medicine internal medicine and other clinical medicineFemaleGeriatrics and Gerontologybusinessepigenetic clockDemographyFollow-Up Studies
researchProduct

Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome.

2021

Background: Metabolic syndrome is a clinical condition that deserves special attention because it puts the individual at high cardiovascular risk, especially heart attack and stroke. Considering precision medicine, it would be advisable to evaluate the individual cardio-metabolic risk by estimating the coexistence of risk factors (abdominal obesity, low level of High-Density Lipoprotein Cholesterol, High Triglycerides, and small dense Low-Density Lipoproteins sub-classes, hypertension, and elevated fasting glycemia), which could engrave on metabolism increasing cardiovascular mortality. Objective: To identify genetic and epigenetic biomarkers may assist in the possibility of helping follow…

EpigenomicsBioinformaticsEpigenesis GeneticGeneticDrug DiscoverymedicineHumansEpigeneticsAbdominal obesityPharmacologyInflammationMetabolic Syndromebusiness.industryEpigeneticEpigenomeDNA MethylationPrecision medicinemedicine.diseasePrognosisManagementDNA methylationHuman genomePersonalized medicineMetabolic Pathwaysmedicine.symptomMetabolic syndromebusinessBiomarkersCurrent pharmaceutical design
researchProduct

Epigenetic biomarkers: A new perspective in laboratory diagnostics.

2012

Epigenetics comprises the study of chemical modifications in the DNA and histones that regulates the gene expression or cellular phenotype. However, during the last decade this term has evolved after the elucidation of different mechanisms (microRNAs and nuclear organization of the chromosomes) involved in regulating gene expression. Epigenetics and the new designed technologies capable to analyze epigenetic changes (e.g., methylated DNA, miRNAs expression, post-translational modifications on histones among others) have disclosed an appealing scenario that will offer for the biomedical sciences new biomarkers for the study of neurodegenerative diseases, multifactorial complex diseases, rare…

EpigenomicsClinical BiochemistryBiologyBiochemistryEpigenesis GeneticHistonesmicroRNACancer; DNA methylation; Histone; MiRNAs; Rare disease;HumansEpigeneticsPathology MolecularEpigenesisEpigenomicsCancerGeneticsEpigenetic biomarkersBiochemistry (medical)Nuclear organizationGeneral MedicineSequence Analysis DNADNA MethylationHistoneMicroRNAsHistoneDNA methylationbiology.proteinMiRNAsRare diseaseProtein Processing Post-TranslationalBiomarkersClinica chimica acta; international journal of clinical chemistry
researchProduct

Losing DNA methylation at repetitive elements and breaking bad

2021

Abstract Background DNA methylation is an epigenetic chromatin mark that allows heterochromatin formation and gene silencing. It has a fundamental role in preserving genome stability (including chromosome stability) by controlling both gene expression and chromatin structure. Therefore, the onset of an incorrect pattern of DNA methylation is potentially dangerous for the cells. This is particularly important with respect to repetitive elements, which constitute the third of the human genome. Main body Repetitive sequences are involved in several cell processes, however, due to their intrinsic nature, they can be a source of genome instability. Thus, most repetitive elements are usually meth…

EpigenomicsGenome instabilityHeterochromatinSatellitesReviewRepetitive DNABiologyQH426-47003 medical and health sciencesLINE-10302 clinical medicineDNA hypomethylationGeneticsHumansEpigeneticsAutism spectrum disorderRepeated sequenceMolecular BiologyRepetitive Sequences Nucleic Acid030304 developmental biologyCancerGenetics0303 health sciencesHereditary diseasesDNA MethylationChromatinChromatinSettore BIO/18 - GeneticaLong Interspersed Nucleotide ElementsICF syndromeDNA methylationHuman genomeAlzheimer’s disease030217 neurology & neurosurgeryNeuropsychiatric disordersDNA hypomethylationEpigenetics & Chromatin
researchProduct

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.

2012

Background: Accurate outcome prediction in neuroblastoma, which is necessary to enable the optimal choice of risk-related therapy, remains a challenge. To improve neuroblastoma patient stratification, this study aimed to identify prognostic tumor DNA methylation biomarkers.Results: To identify genes silenced by promoter methylation, we first applied two independent genome-wide methylation screening methodologies to eight neuroblastoma cell lines. Specifically, we used re-expression profiling upon 5-aza-2'-deoxycytidine (DAC) treatment and massively parallel sequencing after capturing with a methyl-CpG-binding domain (MBD-seq). Putative methylation markers were selected from DAC-upregulated …

EpigenomicsMYCN Single CopyMedizinPrimary Neuroblastoma TumorBioinformaticsNeuroblastoma0302 clinical medicineRisk FactorsMYCN StatusDatabases GeneticPromoter MethylationGTP-Binding Protein alpha Subunits GsHazard Ratio PatientPromoter Regions GeneticEpigenomicsRegulation of gene expression0303 health sciencesMassive parallel sequencingHigh-Throughput Nucleotide SequencingMethylation3. Good healthGene Expression Regulation NeoplasticMedizinische Fakultät » Universitätsklinikum Essen » Zentrum für Kinder- und Jugendmedizin030220 oncology & carcinogenesisDNA methylationAzacitidineBiologieBiologyDecitabine03 medical and health sciencesneuroblastomaCell Line TumorNeuroblastomaBiomarkers TumorChromograninsmedicineHumansddc:61ddc:610Epigenetics030304 developmental biologyepigeneticsGenome HumanResearchBiology and Life SciencesbiomarkersSequence Analysis DNADNA MethylationHCT116 Cellsmedicine.diseaseSurvival AnalysisCancer researchHuman genomeDNA-methylation
researchProduct

Blood and skeletal muscle ageing determined by epigenetic clocks and their associations with physical activity and functioning

2021

AbstractThe aim of this study was to investigate the correspondence of different biological ageing estimates (i.e. epigenetic age) in blood and muscle tissue and their associations with physical activity (PA), physical function and body composition. Two independent cohorts (N = 139 and N = 47) were included, whose age span covered adulthood (23–69 years). Whole blood and m. vastus lateralis samples were collected, and DNA methylation was analysed. Four different DNA methylation age (DNAmAge) estimates were calculated using genome-wide methylation data and publicly available online tools. A novel muscle-specific methylation age was estimated using the R-package ‘MEAT’. PA was measured with q…

EpigenomicsMale0301 basic medicineAgingmaximal oxygen consumptionbiological ageingMonozygotic twinPhysiologyEpigenesis GeneticCohort Studies0302 clinical medicinetwin studyGenetics (clinical)Whole blood0303 health sciencesDNA methylationDual-energy X-ray absorptiometryTwin studyMiddle AgedDNA-metylaatiomedicine.anatomical_structuremuscle massepigenetiikkaDNA methylationFemaledual-energy X-ray absorptiometryAdultMuscle tissueBiologyYoung Adult03 medical and health sciencesMaximal oxygen consumptionmaksimaalinen hapenottoGeneticsmedicineHumansEpigeneticsMuscle SkeletalExerciseMolecular BiologyAged030304 developmental biologykaksostutkimusMuscle strengthResearchSkeletal muscleMuscle massCardiorespiratory fitnessBiological ageingTwin studyikääntyminen030104 developmental biologylihasmassaAgeing3121 General medicine internal medicine and other clinical medicinemuscle strength030217 neurology & neurosurgerylihasvoimaDevelopmental BiologyClinical Epigenetics
researchProduct

Epigenomics and metabolomics reveal the mechanism of the APOA2-saturated fat intake interaction affecting obesity

2018

BACKGROUND: The putative functional variant −265T>C (rs5082) within the APOA2 promoter has shown consistent interactions with saturated fatty acid (SFA) intake to influence the risk of obesity. OBJECTIVE: The aim of this study was to implement an integrative approach to characterize the molecular basis of this interaction. DESIGN: We conducted an epigenome-wide scan on 80 participants carrying either the rs5082 CC or TT genotypes and consuming either a low-SFA (C genotype, promoting an APOA2 expression difference between APOA2 genotypes on a high-SFA diet, and modulating BCAA and tryptophan metabolic pathways. These findings identify potential mechanisms by which this highly reproducible ge…

EpigenomicsMale0301 basic medicineGenotypeMedicine (miscellaneous)030204 cardiovascular system & hematologyBiologyBioinformatics03 medical and health sciences0302 clinical medicineFramingham Heart StudyMetabolomicsGenotypemedicineHumansMetabolomicsDrug InteractionsObesityEpigeneticsAgedEpigenomicsNutrition and DieteticsApolipoprotein A-Ifood and beveragesGenetic VariationEpigenomeDNA MethylationMiddle AgedLipid Metabolismmedicine.diseaseDietary FatsObesityOriginal Research Communications030104 developmental biologyGene Expression RegulationSaturated fatty acidCpG IslandsFemaleApolipoprotein A-IIThe American Journal of Clinical Nutrition
researchProduct

A familial disorder of altered DNA-methylation

2014

BackgroundIn a subset of imprinting disorders caused by epimutations, multiple imprinted loci are affected. Familial occurrence of multilocus imprinting disorders is rare.Purpose/objectiveWe have investigated the clinical and molecular features of a familial DNA-methylation disorder.MethodsTissues of affected individuals and blood samples of family members were investigated by conventional and molecular karyotyping. Sanger sequencing and RT-PCR of imprinting-associated genes (NLRP2, NLRP7, ZFP57, KHDC3L, DNMT1o), exome sequencing and locus-specific, array-based and genome-wide technologies to determine DNA-methylation were performed.ResultsIn three offspring of a healthy couple, we observed…

EpigenomicsMaleGeneticsSanger sequencingDNA Mutational AnalysisGenetic Diseases InbornInfant NewbornMedizinDNA MethylationBiologyPedigreesymbols.namesakeDNA methylationGeneticssymbolsHumansFemaleEpigeneticsImprinting (psychology)Genomic imprintingGeneAllelesGenetics (clinical)Exome sequencingEpigenomics
researchProduct

Placental DNA methylation signatures of maternal smoking during pregnancy and potential impacts on fetal growth.

2021

We would like to thank all the families that participated in these studies for their generous contribution. Detailed acknowledgements and funding can be found in Sup plementary Material.

EpigenomicsMaternal smokingPlacentaGeneral Physics and AstronomyReproductive health and childbirthBioinformaticsLow Birth Weight and Health of the NewbornEpigenesis GeneticFetal DevelopmentPregnancyInfant MortalityFetal growth2.1 Biological and endogenous factorsAetiologyPediatricMultidisciplinaryQSmokingCord bloodDNA methylationEpigeneticsFemalemedicine.symptomScience1.1 Normal biological development and functioningInflammationFetus -- Trastorns del creixementBiologyGeneral Biochemistry Genetics and Molecular BiologyArticleGenetic HeterogeneityGeneticPretermUnderpinning researchTobaccomedicineGeneticsHumansEpigeneticsConditions Affecting the Embryonic and Fetal PeriodsNucleotide MotifsPregnancyHormone activitydNaMGeneral ChemistryEpigenomeDNA MethylationPerinatal Period - Conditions Originating in Perinatal Periodmedicine.diseaseEmbarassades -- Consum de tabacGood Health and Well BeingRisk factorsEpigenesis
researchProduct